UniProt ID | NR2C1_HUMAN | |
---|---|---|
UniProt AC | P13056 | |
Protein Name | Nuclear receptor subfamily 2 group C member 1 | |
Gene Name | NR2C1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 603 | |
Subcellular Localization | Nucleus . Nucleus, PML body. Recruited by HDAC3, after all-trans retinoic acid stimulated MAPK1-mediated Thr-223 phosphorylation, to PML bodies for subsequent sumoylation.. | |
Protein Description | Orphan nuclear receptor. Binds the IR7 element in the promoter of its own gene in an autoregulatory negative feedback mechanism. Primarily repressor of a broad range of genes. Binds to hormone response elements (HREs) consisting of two 5'-AGGTCA-3' half site direct repeat consensus sequences. Together with NR2C2, forms the core of the DRED (direct repeat erythroid-definitive) complex that represses embryonic and fetal globin transcription. Also activator of OCT4 gene expression. May be involved in stem cell proliferation and differentiation. Mediator of retinoic acid-regulated preadipocyte proliferation.. | |
Protein Sequence | MATIEEIAHQIIEQQMGEIVTEQQTGQKIQIVTALDHNTQGKQFILTNHDGSTPSKVILARQDSTPGKVFLTTPDAAGVNQLFFTTPDLSAQHLQLLTDNSPDQGPNKVFDLCVVCGDKASGRHYGAVTCEGCKGFFKRSIRKNLVYSCRGSKDCIINKHHRNRCQYCRLQRCIAFGMKQDSVQCERKPIEVSREKSSNCAASTEKIYIRKDLRSPLTATPTFVTDSESTRSTGLLDSGMFMNIHPSGVKTESAVLMTSDKAESCQGDLSTLANVVTSLANLGKTKDLSQNSNEMSMIESLSNDDTSLCEFQEMQTNGDVSRAFDTLAKALNPGESTACQSSVAGMEGSVHLITGDSSINYTEKEGPLLSDSHVAFRLTMPSPMPEYLNVHYIGESASRLLFLSMHWALSIPSFQALGQENSISLVKAYWNELFTLGLAQCWQVMNVATILATFVNCLHNSLQQDKMSTERRKLLMEHIFKLQEFCNSMVKLCIDGYEYAYLKAIVLFSPDHPSLENMEQIEKFQEKAYVEFQDYITKTYPDDTYRLSRLLLRLPALRLMNATITEELFFKGLIGNIRIDSVIPHILKMEPADYNSQIIGHSI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
21 | Phosphorylation | QQMGEIVTEQQTGQK HHHHHHEECCHHCCE | 33.46 | 23879269 | |
42 | Ubiquitination | LDHNTQGKQFILTNH EECCCCCCEEEEECC | 32.02 | - | |
47 | Phosphorylation | QGKQFILTNHDGSTP CCCEEEEECCCCCCC | 26.20 | 25159151 | |
52 | Phosphorylation | ILTNHDGSTPSKVIL EEECCCCCCCCEEEE | 43.11 | 25159151 | |
53 | Phosphorylation | LTNHDGSTPSKVILA EECCCCCCCCEEEEE | 36.79 | 25159151 | |
55 | Phosphorylation | NHDGSTPSKVILARQ CCCCCCCCEEEEEEC | 39.38 | 29396449 | |
56 | Acetylation | HDGSTPSKVILARQD CCCCCCCEEEEEECC | 34.20 | 26051181 | |
56 | Ubiquitination | HDGSTPSKVILARQD CCCCCCCEEEEEECC | 34.20 | - | |
64 | Phosphorylation | VILARQDSTPGKVFL EEEEECCCCCCEEEE | 28.32 | 17001009 | |
65 | Phosphorylation | ILARQDSTPGKVFLT EEEECCCCCCEEEEE | 44.33 | 28985074 | |
72 | Phosphorylation | TPGKVFLTTPDAAGV CCCEEEEECCCCCCC | 25.48 | 27251275 | |
73 | Phosphorylation | PGKVFLTTPDAAGVN CCEEEEECCCCCCCC | 22.71 | 27251275 | |
90 | Phosphorylation | FFTTPDLSAQHLQLL EEECCCCCHHHHHHH | 33.01 | 22199227 | |
98 | Phosphorylation | AQHLQLLTDNSPDQG HHHHHHHCCCCCCCC | 41.55 | 22199227 | |
101 | Phosphorylation | LQLLTDNSPDQGPNK HHHHCCCCCCCCCCC | 32.44 | 22199227 | |
119 | Ubiquitination | LCVVCGDKASGRHYG EEEEECCCCCCCCCE | 29.72 | - | |
148 | O-linked_Glycosylation | IRKNLVYSCRGSKDC HHCCCCEECCCCCCE | 7.00 | 30379171 | |
152 | Phosphorylation | LVYSCRGSKDCIINK CCEECCCCCCEEECH | 13.13 | 24719451 | |
188 | Ubiquitination | DSVQCERKPIEVSRE CCEECCCCCEEECHH | 28.22 | - | |
196 | Acetylation | PIEVSREKSSNCAAS CEEECHHHCCCCCCC | 59.06 | 30590901 | |
197 | Phosphorylation | IEVSREKSSNCAAST EEECHHHCCCCCCCC | 23.25 | - | |
204 | Phosphorylation | SSNCAASTEKIYIRK CCCCCCCCCEEEEEC | 36.25 | 28985074 | |
208 | Phosphorylation | AASTEKIYIRKDLRS CCCCCEEEEECCCCC | 13.02 | 22817900 | |
215 | Phosphorylation | YIRKDLRSPLTATPT EEECCCCCCCCCCCE | 31.40 | 29255136 | |
218 | Phosphorylation | KDLRSPLTATPTFVT CCCCCCCCCCCEEEC | 31.69 | 29255136 | |
220 | Phosphorylation | LRSPLTATPTFVTDS CCCCCCCCCEEECCC | 20.02 | 29255136 | |
222 | Phosphorylation | SPLTATPTFVTDSES CCCCCCCEEECCCCC | 26.78 | 29255136 | |
225 | Phosphorylation | TATPTFVTDSESTRS CCCCEEECCCCCCCC | 29.62 | 22199227 | |
227 | Phosphorylation | TPTFVTDSESTRSTG CCEEECCCCCCCCCC | 24.87 | 26074081 | |
229 | Phosphorylation | TFVTDSESTRSTGLL EEECCCCCCCCCCCC | 32.83 | 26074081 | |
230 | Phosphorylation | FVTDSESTRSTGLLD EECCCCCCCCCCCCC | 25.29 | 26074081 | |
233 | Phosphorylation | DSESTRSTGLLDSGM CCCCCCCCCCCCCCC | 28.67 | 22210691 | |
238 | Phosphorylation | RSTGLLDSGMFMNIH CCCCCCCCCCEEEEC | 31.93 | 22210691 | |
247 | Phosphorylation | MFMNIHPSGVKTESA CEEEECCCCCCCCEE | 41.90 | 22210691 | |
250 | Sumoylation | NIHPSGVKTESAVLM EECCCCCCCCEEEEE | 50.53 | 28112733 | |
251 | Phosphorylation | IHPSGVKTESAVLMT ECCCCCCCCEEEEEE | 32.53 | 20068231 | |
392 | Phosphorylation | PEYLNVHYIGESASR CCCCCEEEECCHHHH | 13.31 | - | |
424 | Phosphorylation | LGQENSISLVKAYWN HCCCCCHHHHHHHHH | 27.25 | 24719451 | |
523 | Ubiquitination | ENMEQIEKFQEKAYV CCHHHHHHHHHHHHH | 54.71 | - | |
529 | Phosphorylation | EKFQEKAYVEFQDYI HHHHHHHHHHHHHHH | 16.16 | 26074081 | |
538 | Ubiquitination | EFQDYITKTYPDDTY HHHHHHHHHCCCCHH | 36.18 | - | |
581 | Phosphorylation | IGNIRIDSVIPHILK HCCEEECCHHHHHHC | 21.41 | - | |
581 | O-linked_Glycosylation | IGNIRIDSVIPHILK HCCEEECCHHHHHHC | 21.41 | 30379171 | |
588 | Sumoylation | SVIPHILKMEPADYN CHHHHHHCCCCCCCC | 40.38 | 28112733 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
222 | T | Phosphorylation | Kinase | MAPK1 | P28482 | Uniprot |
581 | S | Phosphorylation | Kinase | PKC | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
222 | T | Phosphorylation |
| - |
222 | T | Sumoylation |
| - |
581 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NR2C1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-215 AND THR-220, ANDMASS SPECTROMETRY. |